| Bioactivity | GPR120 Agonist 2 is a GPR120 agonist extracted from patent US 20110313003 A1, example 209. | ||||||||||||
| Target | GPR120 | ||||||||||||
| Invitro | GPR120 Agonist 2 is a GPR120 agonist which is useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control[1]. | ||||||||||||
| Name | GPR120 Agonist 2 | ||||||||||||
| CAS | 1234844-11-1 | ||||||||||||
| Formula | C22H25ClO4 | ||||||||||||
| Molar Mass | 388.88 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Dong Fang Shi, et al. Gpr120 receptor agonists and uses thereof. US20110313003. |